Veena Rao
Directeur/Membre du Conseil chez PREDICTIVE ONCOLOGY INC.
Fortune : 15 134 $ au 30/04/2024
Profil
Veena Rao is an Independent Director at Predictive Oncology, Inc. and the President & Chief Business Officer at Portal Instruments, Inc. She previously worked as a Director at Thermalin, Inc. and as the Chief Commercial Officer at Beta Bionics, Inc. Dr. Rao holds a doctorate degree from Stanford University, an undergraduate degree from the University of Minnesota, and an MBA from the University of Virginia Darden School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PREDICTIVE ONCOLOGY INC
0,22% | 05/04/2024 | 9 117 ( 0,22% ) | 15 134 $ | 30/04/2024 |
Postes actifs de Veena Rao
| Sociétés | Poste | Début |
|---|---|---|
| PREDICTIVE ONCOLOGY INC. | Directeur/Membre du Conseil | 02/05/2023 |
Portal Instruments, Inc.
 Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | President | 01/12/2022 |
Anciens postes connus de Veena Rao
| Sociétés | Poste | Fin |
|---|---|---|
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/08/2022 |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Directeur/Membre du Conseil | - |
Formation de Veena Rao
| University of Minnesota | Undergraduate Degree |
| Stanford University | Doctorate Degree |
| University of Virginia Darden School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Portal Instruments, Inc.
Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Health Technology |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Health Technology |
